[Drug marketing: methods, effect and regulation]
Jens Søndergaard1, Mette Marie Koefoed, Morten Andersen
1Forskningsenheden for Almen Medicin, Institut for Sundhedstjenesteforskning, Syddansk Universitet, DK-5000 Odense C. jsoendergaard@health.sdu.dk
Ugeskrift for Laeger
|March 7, 2009
Summary
Pharmaceutical marketing influences physician prescribing habits, potentially leading to inappropriate prescriptions. Regulation is needed to minimize non-rational prescribing due to this inevitable interaction.
Area of Science:
- Medical Marketing
- Pharmaceutical Industry Ethics
- Physician Prescribing Behavior
Background:
- The relationship between pharmaceutical companies and physicians is a subject of significant recent discussion.
- Pharmaceutical marketing strategies include advertising, sales representative visits, free drug samples, gifts, and event sponsorships.
- Evidence suggests these marketing interactions can inappropriately influence physician prescription patterns.
Purpose of the Study:
- To examine the impact of pharmaceutical marketing on physician prescribing.
- To explore regulatory strategies for mitigating non-rational prescribing influenced by industry interactions.
Main Methods:
- Literature review of studies on pharmaceutical marketing and physician behavior.
- Analysis of marketing tactics employed by pharmaceutical companies.
- Examination of existing regulations and their effectiveness.
Main Results:
- Pharmaceutical marketing significantly influences physician prescribing decisions.
- Common marketing tactics are associated with increased prescription of promoted drugs.
- Current regulations may not be sufficient to prevent inappropriate prescribing.
Conclusions:
- The interaction between pharmaceutical companies and physicians is unavoidable and impacts prescribing.
- Regulatory measures are essential to ensure rational prescribing and patient welfare.
- Further research into effective regulation of pharmaceutical marketing is warranted.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:25Drug Classes and Categories
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).